Long-Term Outcomes of De-Escalated 30-Gy Elective Irradiation in HPV-Associated Oropharyngeal Cancer

IF 23.9 1区医学 Q1 ONCOLOGY

JAMA Oncology Pub Date : 2026-10-22 DOI:10.1001/jamaoncol.2026.4014

Amir H. Safavi, E. Christopher Dee, C. Jillian Tsai, Yingzhi Wu, Sean M. McBride, Daphna Y. Gelblum, Yao Yu, Linda C. Chen, Kaveh Zakeri, Achraf Shamseddine, Jung J. Kang, Hannah Joy, Allison Sheih, Diana Roth O’Brien, Jennifer R. Cracchiolo, Richard J. Wong, Marc A. Cohen, Ian Ganly, Lara A. Dunn, Alan L. Ho, Eric J. Sherman, Nadeem Riaz, Nancy Y. Lee

引用次数: 0

Abstract

This cohort study describes 5-year outcomes following a de-escalated 30-Gy elective nodal irradiation regimen during definitive concurrent chemoradiotherapy among patients with human papillomavirus–associated oropharyngeal carcinoma.

查看原文本刊更多论文

降级30 gy选择性照射治疗hpv相关口咽癌的长期疗效

本队列研究描述了人乳头瘤病毒相关口咽癌患者在确定的同步放化疗期间，采用降级的30 gy选择性淋巴结照射方案后的5年结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JAMA Oncology Medicine-Oncology

自引率

1.80%

发文量

423

期刊介绍： JAMA Oncology is an international peer-reviewed journal that serves as the leading publication for scientists, clinicians, and trainees working in the field of oncology. It is part of the JAMA Network, a collection of peer-reviewed medical and specialty publications.